Upon activation of β3-AR with BRL37344, the concentrations of ALT, AST, TGs, TC, and LDL-C in plasma and of TGs and TC in liver tissues were significantly decreased in the NAFLD models (Fig. 3 and Table 2). This evidence concerns the gene ADRB3 and metabolic dysfunction-associated steatotic liver disease.